Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Boland
Single-Chain Antibody-Based Immunotoxins Targeting Her2/Neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity
Molecular Cancer Therapeutics
Cancer Research
Oncology
(327) Alterations in Mood Are Associated With Dysfunctional Effective Connectivity in the Default Mode Network (DMN), Reward and Memory Related Brain Regions in a Chronic Pain Population
Journal of Pain
Neurology
Anesthesiology
Pain Medicine
Related publications
Molecular Engineering of High Affinity Single-Chain Antibody Fragment for Endothelial Targeting of Proteins and Nanocarriers in Rodents and Humans
Journal of Controlled Release
Pharmaceutical Science
HER2/neu: An Increasingly Important Therapeutic Target. Part 2: Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology
Clinical Investigation
Spectral Fluorescence Molecular Imaging of Lung Metastases Targeting HER2/neu
Clinical Cancer Research
Cancer Research
Oncology
Construction and Characterization of Novel, Completely Human Serine Protease Therapeutics Targeting Her2/Neu
Molecular Cancer Therapeutics
Cancer Research
Oncology
699. shRNA Sense Strand Neutralization Reduces Off-Targeting, Ameliorates Toxicity and Enhances Efficacy of RNAi-Based HBV Gene Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Activating Mutations in HER2 : Neu Opportunities and Neu Challenges
Cancer Discovery
Oncology
Targeting Adenoviruses With Factor X–Single-Chain Antibody Fusion Proteins
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Targeting Nanodisks via a Single Chain Variable Antibody – Apolipoprotein Chimera
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer
PLoS ONE
Multidisciplinary